Research

A recently published national survey collected data on cannabis use for pets.

A cannabis-based treatment was shown to be effective for cognitive disfunctions.

Healer’s first webinar of the year provided a research update on studies examining cannabis used as a treatment for different neurologic conditions.

A new study involving veterans reported beneficial effects of ibogaine as a therapeutic treatment.

In this article, we dive deeper into the physical, cellular, and molecular adaptions that plants demonstrate in response to light intensity and spectrum.

A recent study tested the safety and efficacy of cannabidiol in relieving emergency dental pain.

Researchers analyzed several bone samples from a hospital crypt and detected two cannabinoids.

A study of a small sample of young adults compared cannabis, alcohol, and cigarette use before and after recreational cannabis became legal.

A study involving cannabigerol (CBG) injections in mice tested the effectiveness in pain reduction.

An upcoming clinical trial will test a unique CBD treatment for Autism Spectrum Disorder symptoms in children.

The study resulted in several findings on cannabis use and connections to physical and mental health conditions.

This blog installment looks at the use of cannabis for pets. Topics covered include the history of cannabis use in veterinary medicine, current laws on cannabis for pets, market size and segment, reported experiences from both pet owners and veterinarians, and pet toxicology.

The University of Buffalo has received a grant from the NIH National Cancer Institute to research cannabis’s medicinal effect on cancer immunotherapy treatment.

Our sister publication, Nutritional Outlook, recently published an article about how hair health could turn into another promising market for CBD.

A survey conducted by EO Care, Inc., showed that Americans would be more inclined to use cannabis to treat their health conditions if they were guided by a clinician.

A recent study conducted in Canada with over 1,200 participants has found that psilocybin may significantly alleviate psychological distress resulting from childhood trauma, particularly benefitting those with more severe adversity, suggesting its therapeutic potential in addressing long-lasting trauma-related symptoms.

This blog installment takes a look at the mind-body connection and how the endocannabinoid system (ECS) plays a key role. Topics covered include the gut, the vagus nerve, the gut-brain axis, and more.

The 18-month trial will study the effects of a cannabis extract as part of treatment for brain cancer.

Cannabis Science Conference Fall was held in Providence, Rhode Island from September 20-22, 2023. Here we provide highlights from this exciting event.

A study found that cannabis users that were infected by the COVID-19 virus, experienced ‘better outcomes and mortality’ than non-cannabis users.

Various efforts to attract non-white participants to the study have not succeeded, putting the study in jeopardy.

The study’s principal investigator recently provided more information about the new trial compared to a previous one in 2017.

In this new interview series, we sit down with several speakers from 2023 Cannabis Science Conference events to learn about their expertise and backgrounds in the cannabis industry. Join us to learn more about Dr. Peter Grinspoon, Jini Glaros, Dr. Miyabe Shields, and Adam Jacques.

A recent study in Molecular Psychiatry suggests CBD use during pregnancy may harm fetal brain development, posing a cognitive risk.

Let’s meet Riley Kirk, PhD, cannabis and natural product chemist, cannabis educator, and cannabis research scientist.